Saghmos Therapeutics' Unattributed Round

Saghmos Therapeutics raised a round of funding on April 17, 2018.

Saghmos Therapeutics is a biopharmaceutical company whose mission is to prevent and treat kidney injury due to contrast dyes.…

Articles about Saghmos Therapeutics' Unattributed Round: